Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Eli Lilly and Company announces first Lilly Gateway Labs facility in San Diego for 2024 In a strategic move to strengthen its position in the life sciences sector, Eli Lilly and Company (NYSE:… byPallavi MadhirajuNovember 29, 2023